
SIGA Technologies Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Stock Performance (90 Days)
Layoff History
Recent News
Other Drug Manufacturers - Specialty & Generic Companies
View All →Frequently Asked Questions
Has SIGA TECHNOLOGIES INC had layoffs?
How many employees does SIGA TECHNOLOGIES INC have?
What industry is SIGA TECHNOLOGIES INC in?
Is SIGA TECHNOLOGIES INC a publicly traded company?
Where is SIGA TECHNOLOGIES INC headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.